Sealant foam compositions for lung applications
US10980913B2 · kind B2 · utility
0Cited by
23References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2018 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Mar 5, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08J2471/02
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention is directed to tissue sealant compositions comprising: a multi-arm reactive polyethylene glycol polymer having at least 3 electrophilic groups; albumin; a buffer; water; and entrained gas as bubbles; wherein concentration of albumin in a liquid component of the sealant is within range of 50-200 mg/ml; and wherein concentration of multi-arm PEG in said liquid component of the sealant is within range of 25-100 mg/mL.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.